AGA releases updated guidelines on hepatitis B reactivation in patients on immunosuppressive drugs

The American Gastroenterological Association (AGA) has unveiled an updated clinical practice guideline in Gastroenterology addressing the prevention and management of hepatitis B virus reactivation (HBVr) in patients on immunosuppressive drugs.

Stimulant users are caught in fatal ‘fourth wave’ of opioid epidemic

In Pawtucket, Rhode Island, near a storefront advertising “free” cellphones, J.R. sat in an empty back stairwell and showed a reporter how he tries to

January 3, 2025

ILution travoprost by Glaukos for Ocular Hypertension: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

June 21, 2024

Ribon Therapeutics rids preclinical work, trims staff to focus on two clinical PARP inhibitors

Ribon Therapeutics, a biotech looking to make next-generation oral PARP inhibitors, has ended preclinical and platform work to focus on two clinical programs. “Cuts across

July 29, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.